INTRODUCTION
Psoriasis is a common, chronic, immune-mediated inflammatory skin disease that affects approximately 2-3% of the world population. 1 Recent findings suggest that previous concept considering psoriasis as a "disease of healthy people" should be revised
into "psoriasis as a complex and multisystemic disease" with a profound negative impact on a patient's quality of life. [2] [3] [4] [5] The existing literature shows that psoriasis is associated with an increased prevalence of cardiovascular risk factors, increased risk of myocardial infarction and stroke, and an excess of cardiovascular mortality. [6] [7] [8] [9] [10] The metabolic syndrome (MetS) is a cluster of cardiovascular risk factors including abdominal obesity, hypertension, atherogenic dyslipidemia (raised triglycerides and low concentrations of high-density lipoprotein cholesterol [HDL-C] level), and glucose intolerance which has been shown to predict cardiovascular disease (CVD) and diabetes mellitus (DM).
47
Emerging epidemiological evidence suggests a significant association between psoriasis and MetS and its components. [12] [13] [14] [15] The link between psoriasis and the MetS has not been completely elucidated but it seems that both entities have common pathophysiology with underlying chronic inflammatory status.
11, 16 The aim of this study was to investigate the prevalence of MetS and its components in patients with psoriasis and to compare them with control subjects without psoriasis. We also aimed to determine relation between disease severity and prevalence of MetS and its components, and to assess the prediction of MetS in psoriatic patients. A short structured questionnaire was used to collect data regarding age, gender, smoking habits, physical activity, age of psoriasis onset, duration of the disease and drug treatment with antihypertensive, hypo-glycemic, or lipid-lowering drugs.
METHODS

Patients and study design
Smoking status was categorized as never, former, and current. Physical activity was measured with a question: "In your leisure time, how often do you do physical exercise for at least 30 min that makes you at least mildly short of breath or perspire?" Those who participated in physical activity four times or more per week were categorized as active, those who exercised less than four times a week but at least 2-3 times a month were categorized as moderately (in)active and those who exercised several times a year or did not exercise at all were categorized as inactive.
For the assessment of psoriasis severity Psoriasis Area and Severity Index (PASI) and Body Surface Area (BSA) were used. Psoriasis was considered as mild if the PASI score was <10, moderate if the PASI score was between 10 and 20, and severe if the PASI score was >20. 17 According to BSA, in patients with BSA <10% psoriasis was considered as localized, and in those with BSA >10% as disseminated. 18 Anthropometric measures recorded in this study were weight, height and waist circumference. Measures of weight (kilograms) and height (meters) were assessed using a standard physician's scale and a stadiometer, respectively. The body mass index Odds ratios (ORs) and 95% Confidence intervals (CIs) for the association between psoriasis and disease extent and the components of the MetS were calculated using multivariate logistic regression. Adjusted ORs were determined by adjusting for confounders such as age and sex. Multivariate logistic regression analysis (the Enter method) was also used to predict MetS in psoriatic patients.
The dependent variable was absence/presence of MetS, while the independent variables included age of psoriasis onset, duration of psoriasis, PASI and physical activity. The selection of independent variables was based on literature review. [18] [19] [20] [21] Possible correlation between them was estimated by VIF (variance inflation factor). Also, the model was tested for pair-wise interaction between covariates.
Interactions with sex and age were considered. Once the model was fitted to the data, the adequacy of fit was assessed by the
Hosmer-Lemeshow (H-L) test as well as with AUC (Area under the ROC curve).
A two-tailed probability value of 0.05 or less was considered significant. All statistical analyses were performed with the Statistical Package for the Social Sciences, version 20.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
The descriptive data of 244 patients with psoriasis compared to 163 control subjects are shown in table 1.
The mean age was significantly higher for cases than for controls (53.54 vs. 43.69). There were more males than females in the study group. Smoking and lack of physical activities were more frequently observed in psoriatic patients. Waist circumference, triglycerides, systolic and diastolic blood pressure, and CRP levels were significantly higher in the patients with psoriasis compared with control subjects, while HDL-C level was higher in controls.
There were no significant differences regarding BMI and fasting blood glucose.
The prevalence of MetS and its components in patients with overall, mild, moderate and severe psoriasis and in control subjects are shown in table 2.
All the components of MetS, except low level of HDL-C, were significantly higher in psoriatic group compared with con- (Table 4 ). There were no differences between two groups of patients regarding gender, smoking habits, and severity of disease.
According to multivariate logistic regression analysis ( There is substantial evidence from reported studies linking psoriasis with core MetS components, such as hypertension, central obesity, and DM. 14, 30, 31 High blood pressure was the most frequent component of MetS in our psoriatic patients and its prevalence differs significantly between psoriatic patients and patients in the control group (67.2%
vs. 25.8%), but there were no differences according to disease severity. In a large population based study, although the risk for other cardiovascular risk factors was higher in severe psoriasis, a similar association between psoriasis severity and risk of hypertension was PASI: psoriasis area and severity index; BSA: body surface area. However, the largest systematic review and meta-analysis performed to date, with over 309,000 psoriatic patients, revealed that psoriasis was associated with greater prevalence of hypertension and that patients with severe psoriasis had greater odds of hypertension than those with mild psoriasis. 30 The exact mechanism underlying this association is still unknown. Although psoriasis and hypertension have same risk factors such as smoking and obesity, previous studies have shown an independent association between psoriasis and hypertension after adjusting on these factors. 30 Like in a number of previous reports we found that psoriasis was independently associated with an increased prevalence of type 2 DM. 22, 28, [32] [33] [34] In our study an increased risk of DM was observed only in patients with severe psoriasis. A recent large systematic review and meta analysis of observational studies concluded that psoriasis was associated with a 59% increased prevalence of Patients with severe psoriasis may have even higher risk of developing DM. 31 This consistent association between psoriasis and DM suggests a likely pathophysiologic link between the two diseases.
It is believed that insulin resistance underlies the pathogenesis of the MetS. However, the relation between psoriasis and insulin resistance⁄DM remains to be elucidated. 22 Our finding that the prevalence of abdominal obesity is significantly higher in psoriatic patients compared with controls is consistent with previous observations. 12, 14, 18, 19, 28, [34] [35] [36] However, it has been debated whether obesity precedes the development of psoriasis or it is a consequence of psoriasis. [37] [38] [39] Evidence suggests that depression, poor nutrition habits, lack of physical activity, alcohol consumption, stress and chronic inflammation have all been linked to psoriasis and favor obesity. In turn, obesity as a proinflammatory state, associated with increased levels of inflammatory factors such as tumor necrosis factor-alpha, and interleukin 6, can favor psoriasis. Like in several previous studies elevated CRP as key biomarker of systemic inflammation and risk for future vascular disease was more prevalent in psoriatic patients compared with controls. 12, 19, 39, 40 In this study smoking was found to be more prevalent in patients with psoriasis than in controls, that is in accordance with previous findings. 37, 38 A recent large systematic review and meta-analysis revealed an association between psoriasis and smoking, suggesting that smoking is an independent factor for the development of psoriasis. 41 However, like in several previous studies we did not find any statistically significant difference in smoking habits between psoriatic patients with and without MetS. 18, 39 In our study physical inactivity was observed more frequently in patients with psoriasis compared to controls. Psoriatic patients with MetS were less physically active than those without
MetS, but we failed to find an independent relationship between two variables. It is known that lack of physical activity may contribute to the increased risk of CVD in psoriasis patients. Recent evidence suggests shared pathophysiological pathways between psoriasis, its cardiometabolic comorbidities, and physical activity. 42 Later onset and longer duration of psoriasis were independent predicting factors of MetS in our patients. We do not have any explanation why later onset of psoriasis, rather than an early onset, was associated with MetS. However, the association of a longer disease duration and MetS already reported by Gisondi et al. 18 and Nisa and Qazi 29 could be explained with long-lasting chronic inflammation and all its aforementioned consequences.
To the best of our knowledge, this is the first study in Southeastern Europe to report the relation between psoriasis and MetS.
Unlike in many population-based studies in which the diagnosis of psoriasis was self-reported in our study it was confirmed by experienced dermatologists. Selection and information bias are unlikely to explain our results as the patients with psoriasis and control subjects were identified and included from the same hospital and data from all participants were collected in the same manner by experienced dermatologists. Study findings were based on direct measurement
(laboratory values) of the components of MetS, and objectively measured psoriasis severity. In addition we used standard criteria for diagnosis of MetS.
However, several limitations of the present study should be mentioned. First, the cross-sectional design of the study does not allow us to draw directional causal inferences concerning the association between psoriasis and MetS. Second, factors such as diet, alcohol consumption or mental health, which have not been evaluated in this study, may be confounders in this relation. Thirdly, all patients were from a tertiary referral psoriasis centre and consequently a significant portion of patients with severe psoriasis was recruited.
Therefore results may not be transferable to other settings.
CONCLUSION
Our findings demonstrate a strong association between psoriasis and MetS and its components, regardless of psoriasis severity.
Although questions such as whether psoriasis predisposes the patient to MetS or whether metabolic disorders can lead to psoriasis have remained unanswered, the higher prevalence of MetS in patients with psoriasis reported by most studies emphasizes the need for early detection of metabolic disorders and adequate early treatment of psoriasis and its comorbidities through a multidisciplinary approach. 43 Patients with psoriasis should be encouraged to address aggressively their modifiable cardiovascular risk factors, in particular hypertension, obesity, physical inactivity, and smoking habits.q
